Furthermore, a significant decrease in the expression levels of EGFR, Akt, phospho-Akt, mTOR, and phospho-mTOR has been observed following high doses of progesterone, indicating its potential attenuating effect against GBM through the PI3K/Akt and metabolic pathways [68,69,70]. The gene discussed is AKT1; the disease is glioblastoma.